diphtheria and tetanus toxoids


Also found in: Dictionary, Encyclopedia, Wikipedia.
Related to diphtheria and tetanus toxoids: DPT vaccine, DT vaccine

diphtheria and tetanus toxoids (DT)

an active immunizing agent.
indications It is prescribed for immunization against diphtheria and tetanus when pertussis vaccination is contraindicated.
contraindications Immunosuppression, acute infection, or concomitant use of corticosteroids prohibits its use.
adverse effect The most serious adverse reaction is anaphylaxis.
References in periodicals archive ?
The observed antibody responses to diphtheria and tetanus toxoids in the two studies may therefore not be fully comparable.
And in 1996, it was the first company to license a diphtheria, tetanus, and acellular pertussis vaccine for use in infants -- Tripedia(R), Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed.
Another manufacturer quit making diphtheria and tetanus toxoids for pediatric use, leaving only one manufacturer of DT vaccine.
The vaccines against diphtheria and tetanus toxoids adsorbed, reduced antigen content.
i] The full chemical name for PENTACEL(TM) vaccine is: (Haemophilus b Conjugate Vaccine [Tetanus Toxoid Conjugate] - ActHIBEAE Reconstituted with Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Poliovirus Vaccine Inactivated)
TETRAMUNE(R) Diphtheria and Tetanus Toxoids and Pertussis Vaccine Adsorbed and Haemophilus b Conjugate Vaccine (Diphtheria CRM197 Protein Conjugate), the first combination vaccine to help prevent four serious childhood diseases with half the number of shots;
June 26 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that its Pentacel(R), Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine will be included in the federal government's Vaccines for Children (VFC) program.
29, 1996--Wyeth-Lederle Vaccines and Pediatrics, a unit of Wyeth-Ayerst Laboratories, announced today that the Food and Drug Administration's (FDA) Vaccines & Related Biological Products Advisory Committee concluded that ACEL-IMUNE(R) Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed(a) is safe and effective when given to U.
In addition, the ACIP recommended that KINRIX may be given to children 4 to 6 years-old as the fifth dose of Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTaP) and the fourth dose of Inactivated Poliovirus (IPV).
KINRIX is approved for children 4 to 6 years of age whose previous Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTaP) vaccinations have been with PEDIARIX(R) [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined] and/or INFANRIX(R) [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed].